PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 19 filers reported holding PTC THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,732,000 | -0.7% | 15,519,000 | 0.0% | 0.35% | +14.6% |
| Q1 2022 | $15,848,000 | -3.8% | 15,519,000 | 0.0% | 0.31% | -10.2% |
| Q4 2021 | $16,480,000 | +1.7% | 15,519,000 | 0.0% | 0.34% | -7.5% |
| Q3 2021 | $16,211,000 | -4.0% | 15,519,000 | 0.0% | 0.37% | +1.4% |
| Q2 2021 | $16,885,000 | -6.1% | 15,519,000 | 0.0% | 0.37% | -20.7% |
| Q1 2021 | $17,981,000 | +14.4% | 15,519,000 | +28.3% | 0.46% | +4.8% |
| Q4 2020 | $15,723,000 | +69.3% | 12,099,000 | +49.4% | 0.44% | +24.9% |
| Q3 2020 | $9,287,000 | – | 8,099,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $25,902,000 | 1.06% |
| PFM Health Sciences, LP | 19,807,000 | $20,605,000 | 0.61% |
| Partner Investment Management, L.P. | 193,000 | $201,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,430,000 | $4,581,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $21,253,000 | 0.27% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,176,000 | $25,210,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,381,000 | 0.07% |
| Verition Fund Management LLC | 1,415,000 | $1,472,000 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 4,298,000 | $4,470,000 | 0.03% |
| LOOMIS SAYLES & CO L P | 248,482 | $8,404,000 | 0.02% |